Company intelligence / Profile preview

北京良远生物医药研究有限公司

Beijing, Beijing, China

Ownership: Private
Development stage: Other

Overview

Beijing Liangyuan Biopharmaceutical Research Co., Ltd. is a Chinese biotechnology company dedicated to the discovery and development of novel small molecule therapeutics. Founded in 2016 and based in Beijing, the company focuses on high-impact therapeutic areas including oncology and inflammatory diseases. Liangyuan Biopharmaceutical utilizes a robust medicinal chemistry platform to design and optimize candidates targeting validated pathways such as EGFR and BTK. The firm operates as an integrated R&D entity, moving programs from early-stage discovery through preclinical development. Its business model combines internal pipeline progression with strategic technical services for the broader pharmaceutical industry.

Therapeutic areas: ImmunologyOncology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on 北京良远生物医药研究有限公司.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 北京良远生物医药研究有限公司.

Explore the full profile